Western Asset Core Bond Fund Commentary – Q2 2021
Thesis
WATFX (currently yielding 1.55%) is an actively managed fund that finds overlooked areas of the market that can go against consensus views and add value. Through internal macro, credit, and fundamental research WATFX identifies undervalued securities and takes on more credit exposure to generate alpha over time. Through a diversified approach to interest rate duration, yield curve, sector allocation, and security selection, the fund dampens exposure to volatility.
[more]
Overview
In the second quarter of 2021, WATFX outperformed the benchmark (Barclays U.S. AGG) by 36bps largely due to the fund’s duration and yield-curve positioning, as well as its investment-grade credit exposure. Spreads tightened in corporate credit and structured products which contributed to overall performance. In general, risk assets performed well for the quarter as inflation data came in surprisingly strong and the FOMC meeting in June resulted in rate hikes being pulled forward.
Q2 2021 Summary
- WATFX returned 2.19%, while the U.S. AGG returned 1.83%
- Quarter-end effective duration for WATFX was 7.10 and 6.58 for the U.S. AGG
- Trimmed duration, agency MBS, and investment-grade and “plain-vanilla” high yield debt
- Increased allocation to EM debt (US dollar-denominated corporate and sovereign bonds), reopening high-yield sectors, residential and commercial structured products, and banks loans
Outlook
- We continue to hold this fund and believe in our thesis due to the fund’s diverse approach and strong top down-bottom up fundamental value investing over the long-term
- Expecting global GDP growth to be strong, with higher inflation as the world economy continues to open
- Spread products should benefit most from reopening
- The fund is excited to seek out opportunities as spreads widen and the Fed continues to support corporate credit markets
[Category Mutual Fund Commentary]
Micah Weinstein
Research Analyst
Direct: 617.226.0032
Fax: 617.523.8118
Crestwood Advisors
One Liberty Square
Suite 500
Boston, MA 02109